(Q51928577)

English

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

scientific article published in December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study. (English)

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

0 references

0 references

1 reference

based on heuristic

inferred from title

(E)-phytonadione

1 reference

based on heuristic

inferred from title

author name string

John F Carlquist

1

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Benjamin D Horne

2

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Joseph B Muhlestein

3

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Donald L Lappé

4

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Bryant M Whiting

5

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Matthew J Kolek

6

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Jessica L Clarke

7

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Brent C James

8

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Jeffrey L Anderson

9

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

publication date

1 December 2006

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

22

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

191-197

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

3

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

https://scigraph.springernature.com/pub.10.1007/s11239-006-9030-7

0 references

Potential anticoagulant drug interactions in ambulatory patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-006-9030-7

21 January 2018

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotyping and phenotyping the cytochrome p-450 enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic analysis of the human cytochrome P450 CYP2C9 locus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the gene for vitamin K epoxide reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/17111199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-006-9030-7

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

1 reference

Europe PubMed Central

17 April 2018

http://europepmc.org/abstract/MED/17111199

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51928577&oldid=1585010732"